Hemolytic anemia has been reported to occur in the setting of aortic stenosis and prosthetic heart valves, but much more rarely in association with obstructive hypertrophic cardiomyopathy (HC). Of the few descriptions of hemolytic anemia secondary to HC, all but one case involved bacterial endocarditis contributing to left ventricular outflow tract obstruction. We present the case of a 67-year-old man with recurrent hemolytic anemia and HC, without infective endocarditis. Attempts at iron repletion and augmentation of beta-blocker therapy proved his anemia to be refractory to medical management. Ventricular septal myectomy led to the resolution of hemolysis, anemia, and its coexisting symptoms.
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H ypertrophic cardiomyopathy (HC) carries with it a constellation of signs and symptoms caused by left ventricular outfl ow tract obstruction and restrictive cardiac physiology (1) . Hemolytic anemia is an exceedingly rare complication of outfl ow tract obstruction. We present a 67-yearold man whose longstanding suff ering from repeated episodes of anemia was resolved with a ventricular septal myectomy.
CASE REPORT
A 67-year-old man with coronary artery disease was referred to the cardiology clinic for evaluation of a precordial systolic murmur in the setting of a 1-year history of recurrent anemia. Over the preceding year, he had received dozens of blood transfusions at outlying facilities for iron-defi ciency anemia and symptoms of dyspnea, fatigue, and weakness. Although a fecal occult blood test was positive, three esophagogastroduodenoscopies, three colonoscopies, and a small bowel study were of no avail in fi nding a source of bleeding. Despite the exhaustive workup and initiation of treatment, responses to oral iron replacement therapy were transient. Furthermore, of signifi cance was the presence of newly found evidence of intravascular hemolysis just prior to the cardiology referral.
Examination revealed a grade 4/6 systolic murmur heard best at the left lower sternal border, which intensifi ed with the Valsalva maneuver. Carotid upstrokes were brisk and neck veins were nondistended. Th e abdomen was soft without splenomegaly. Th e remainder of the general examination was normal. Daily home medications included aspirin, clopidogrel, metoprolol tartrate, simvastatin, and ferrous sulfate. A transthoracic echocar- diogram demonstrated mitral valve systolic anterior motion with a peak left ventricular outfl ow (LVOT) gradient of 92 mm Hg. Th e dose of metoprolol was increased from 100 mg to 200 mg daily. Concurrent with this change, albeit short-lived, was a signifi cant improvement in the patient's presenting symptoms of fatigue and dyspnea.
Over the course of the upcoming months, however, his symptoms resurfaced, as did a reduction in the hemoglobin levels. On a second occasion, the metoprolol dosage was increased from 200 mg to 300 mg a day. Symptoms transiently improved, but he again experienced a relapse of profound anemia, dropping from a hemoglobin level of 14.2 g/dL to 7.0 g/dL. Th e patient successfully underwent a septal myectomy. Follow-up echocardiography showed a peak LVOT gradient of 16 mm Hg. In the succeeding months, the symptoms of chest tightness and breathlessness resolved. His hemoglobin also normalized (Figure) .
DISCUSSION
During the 13 months of care that led up to the septal myectomy, the patient intermittently required blood transfusions for low hemoglobin levels. Multiple upper and lower endoscopies failed to localize a source of bleeding or site of angiodysplasia. In addition to iron-defi ciency anemia, laboratory exams episod ically identifi ed a reticulocyte count of 5.3%, lactate dehydrogenase level of 471 units/L (normal range, 84-246 units/L), an undetectable haptoglobin level, and a total bilirubin of 1.6 mg/dL (normal range, 0.2-1.2 mg/dL), implicating hemolysis. Direct antiglobulin (Coombs) testing was persistently negative. Less common causes of hemolytic anemia to include paroxysmal nocturnal hemoglobinuria, thalassemia, and glucose-6-phosphate dehydrogenase defi ciency were excluded. A bone marrow biopsy displayed erythroid hyperplasia without evidence of dysplasia or immaturity, supporting the role of hemolysis in our patient's anemia.
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Sudhir Thotakura, MD, Steven M. Costa, MD, and Christian Cable, MD Our patient primarily complained of chest pain and dyspnea. Acute coronary syndrome was quickly eliminated as a diagnostic possibility with an electrocardiogram and cardiac biomarkers. Furthermore, the lack of systemic symptoms, such as pyrexia, arthralgias, or weight loss, deters one from considering an infectious etiology involving intracellular pathogens (e.g., malaria). In addition, he endorsed no travel history that might have placed him at risk for such exposures. Th ere was no family history of anemia. He had no signs such as splenomegaly or lymphadenopathy that might direct attention towards malignancy or a lymphoproliferative disorder, but he did have a noteworthy precordial murmur.
Understanding these clues led us to postulate that the patient's known HC was the culprit for his hemolytic anemia. Optimization of intravascular hemodynamics in the setting of obstructive HC is paramount in symptom control. Th e improvement in the dynamic obstruction of the left ventricular outfl ow tract that occurs with HC by the administration of beta-blockers is well established (2). Zezulka et al have described that propranolol can reduce LVOT gradients in cases of HC, thereby reducing red cell shear stress (3). In another case study of a 66-year-old woman with HC suff ering from hemolytic anemia, 3 months of therapy with atenolol reduced her LVOT gradient from 200 mm Hg to 130 mm Hg (4). Th is change was accompanied by improvement of the anemia.
